BRIEF published on 11/09/2026 at 17:50, 9 days 3 hours ago Transgene provides an update on its clinical and financial progress Financial Situation Transgene TG4050 Lung Cancer Myvac®
BRIEF published on 11/09/2026 at 17:50, 9 days 3 hours ago Transgene fait le point sur ses avancées cliniques et financières Situation Financière Transgene TG4050 Cancer Du Poumon Myvac®
PRESS RELEASE published on 11/09/2026 at 17:45, 9 days 3 hours ago Transgene poursuit ses programmes cliniques et fait le point sur sa situation financière au troisième trimestre 2026
BRIEF published on 10/05/2026 at 08:05, 1 month 13 days ago Transgene présente son virus oncolytique innovant au SITC 2026 Biotechnologie Immunothérapie Transgene Virus Oncolytique SITC 2026
BRIEF published on 10/05/2026 at 08:05, 1 month 13 days ago Transgene presents its innovative oncolytic virus at SITC 2026 Biotechnology Immunotherapy Transgene Oncolytic Virus SITC 2026
PRESS RELEASE published on 10/05/2026 at 08:00, 1 month 13 days ago Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus at SITC 2026 Transgene to present preclinical data on novel oncolytic virus PoxSTG-EEV at SITC 2026 Annual Meeting in Phoenix, Arizona, November 7, 2026 Preclinical Data Poster Presentation Transgene Oncolytic Virus SITC 2026
PRESS RELEASE published on 10/05/2026 at 08:00, 1 month 13 days ago Transgene présentera un poster sur les données précliniques de son virus oncolytique innovant au SITC 2026 Transgene présentera un poster sur les données précliniques de son virus oncolytique innovant au SITC 2026. Détails du poster et contacts disponibles dans le communiqué de presse Transgene Données Précliniques Virus Oncolytique SITC 2026 Poster
BRIEF published on 09/08/2026 at 07:35, 2 months 10 days ago Transgene and ProBioGen Expand Strategic Collaboration Manufacturing Efficiency Transgene Vaccine Production ProBioGen Biotech Partnership
BRIEF published on 09/08/2026 at 07:35, 2 months 10 days ago Transgene et ProBioGen étendent leur collaboration stratégique Transgene Efficacité De Production ProBioGen Partenariat En Biotechnologie Production De Vaccins
BRIEF published on 09/08/2026 at 07:35, 2 months 10 days ago Transgene et ProBioGen renforcent leur partenariat avec un nouvel accord de licence Partenariat Stratégique Immunothérapie Transgene ProBioGen Lignée Cellulaire
Published on 11/18/2026 at 15:30, 5 hours 52 minutes ago Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
Published on 11/18/2026 at 14:30, 6 hours 52 minutes ago Boron One Announces Non-Binding Heads of Agreement with Multinational Manufacturing Company
Published on 11/18/2026 at 13:35, 7 hours 47 minutes ago ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
Published on 11/18/2026 at 13:30, 7 hours 52 minutes ago NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
Published on 11/18/2026 at 19:30, 1 hour 52 minutes ago LLCP Completes Investment in Empower Technical Services in Partnership with Management
Published on 11/18/2026 at 18:33, 2 hours 49 minutes ago EQS-Adhoc: Medios AG: Medios AG adopts public share buyback program
Published on 11/18/2026 at 18:05, 3 hours 17 minutes ago ALLWYN UNCOVERS 'FEELINGS DEFICIT' AND JOINS FORCES WITH MARIO LOPEZ TO HELP PEOPLE EXPERIENCE MORE FEELINGS THROUGH PLAY
Published on 11/18/2026 at 17:52, 3 hours 30 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 11/18/2026 at 19:14, 2 hours 8 minutes ago Aéroports de Paris S.A - Favourable binding opinion of the French ART
Published on 11/18/2026 at 19:14, 2 hours 8 minutes ago Aéroports de Paris S.A - Avis conforme favorable de l'ART